{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:48:38Z","timestamp":1792169318375,"version":"4.4.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.amjcard.2023.12.039","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T21:04:56Z","timestamp":1703883896000},"page":"182-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hematologic Malignancies and Increased Cardiovascular Risk\u2014Can More Be Done to Mitigate?"],"prefix":"10.1016","volume":"213","author":[{"given":"Ying X.","family":"Gue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2023.12.039_bib0001","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41408-020-0323-4","article-title":"Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century","volume":"10","author":"Pulte","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.amjcard.2023.12.039_bib0002","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.amjcard.2023.11.039","article-title":"Cardiovascular risk in patients with hematological malignancies: a systematic review and meta-analysis of 1,960,144 cases","volume":"212","author":"Yong","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2023.12.039_bib0003","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1055\/s-0042-1756355","article-title":"Clinical complexity domains, anticoagulation, and outcomes in patients with atrial fibrillation: a report from the Gloria-AF registry phase II and III","volume":"122","author":"Romiti","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2023.12.039_bib0004","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1055\/a-1467-2993","article-title":"Improving stroke risk prediction in the general population: a comparative assessment of common clinical rules, a new multimorbid index, and machine-learning-based algorithms","volume":"122","author":"Lip","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2023.12.039_bib0005","doi-asserted-by":"crossref","unstructured":"Grymonprez M, Petrovic M, De Backer TL, Steurbaut S, Lahousse L. The impact of polypharmacy on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation [published online June 27, 2023]. Thromb Haemost. https:\/\/doi.org\/10.1055\/s-0043-1769735.","DOI":"10.1055\/s-0043-1769735"},{"key":"10.1016\/j.amjcard.2023.12.039_bib0006","doi-asserted-by":"crossref","unstructured":"Zheng Y, Li S, Liu X, Lip GYH, Guo L, Zhu W. Effect of oral anticoagulants in atrial fibrillation patients with polypharmacy: a meta-analysis [published online July 3, 2023]. Thromb Haemost. https:\/\/doi.org\/10.1055\/s-0043-1770724.","DOI":"10.1055\/s-0043-1770724"},{"key":"10.1016\/j.amjcard.2023.12.039_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2022.101353","article-title":"Thrombosis and bleeding in hematological malignancy","volume":"35","author":"Wang","year":"2022","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.amjcard.2023.12.039_bib0008","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1055\/s-0042-1750385","article-title":"Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific expert consensus paper","volume":"122","author":"Gorog","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2023.12.039_bib0009","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.12.039_bib0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0041-1739411","article-title":"2021 Focused update consensus guidelines of the Asia Pacific heart rhythm society on stroke prevention in atrial fibrillation: executive summary","volume":"122","author":"Chao","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2023.12.039_bib0011","first-page":"36","article-title":"DOACs for stroke prevention in patients with AF and cancer","volume":"27","author":"Mehta","year":"2020","journal-title":"Br J Cardiol"},{"key":"10.1016\/j.amjcard.2023.12.039_bib0012","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hon.2770","article-title":"Direct oral anticoagulants in patients with hematologic malignancies","volume":"38","author":"Serrao","year":"2020","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.amjcard.2023.12.039_bib0013","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s11239-022-02702-9","article-title":"Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies","volume":"54","author":"Serrao","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.amjcard.2023.12.039_bib0014","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/a-1591-8033","article-title":"Integrated care systems and the Aortovascular hub","volume":"122","author":"Field","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2023.12.039_bib0015","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/a-1632-1777","article-title":"\"Novel Clinical Concepts in Thrombosis\": integrated care for stroke management-easy as abc","volume":"122","author":"Lip","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2023.12.039_bib0016","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/a-1515-9630","article-title":"Adherence to the 'atrial fibrillation better care' pathway in patients with atrial fibrillation: impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients","volume":"122","author":"Romiti","year":"2022","journal-title":"Thromb Haemost"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923014443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923014443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:02:37Z","timestamp":1792166557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914923014443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":16,"alternative-id":["S0002914923014443"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.12.039","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematologic Malignancies and Increased Cardiovascular Risk\u2014Can More Be Done to Mitigate?","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.12.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.11.039","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}